TPD & Induced Proximity Summit Leaderboard
  • Tuesday, July 7, 2026
  • About
  • Advertise
  • Subscribe
  • Contact

Pharma Journalist Pharma Journalist -

Oligonucleotides Analytical Development & CMC Summit Leaderboard
  • Home
  • News
  • Drug Research
  • Clinical Trials
  • Manufacturing
  • Information Technology
  • Packaging & Labeling
  • Diseases
  • Resources
    • Articles
    • Projects
    • Case Studies
    • Industry Reports
    • Interviews
    • White Papers
  • Events
  • Press Releases
Pharma Journalist
  • Home
  • Pharma Journalist
  • Page 375

Author

Pharma Journalist 8916 posts 0 comments

AnHeart Therapeutics and Innovent Biologics Announce Exclusive License Agreement for Taletrectinib…

Jun 1, 2021
AnHeart Therapeutics Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, and Innovent Biologics, Inc. an innovative leading biopharmaceutical…
Read More...

Registration is open for SMi’s 2nd Annual Next Generation Pharmaceutical Cleanroom

Jun 1, 2021
SMi Reports: Registration is now open for the 2nd Annual Next Generation Pharmaceutical Cleanroom Conference will convene in London on 6th and 7th October 2021 Following on from the…
Read More...

Samsung Biologics to add mRNA vaccine drug substance manufacturing suite to expand portfolio of…

May 31, 2021
Samsung Biologics announced its plans to add mRNA vaccine drug substance (DS) manufacturing capability to the current facility in Songdo, ready for cGMP operations within the earlier…
Read More...

Key updates ahead of SMi’s 4th Annual Pharmaceutical Microbiology West Coast Virtual Conference in…

May 28, 2021
SMi Group Reports: Key updates released ahead of SMi’s 4th Annual Pharmaceutical Microbiology West Coast Conference, convening in just three weeks. SMi Group are delighted to…
Read More...

Antengene Announces First Patient Dosed in Phase I/II Trial of Eltanexor for the Treatment of…

May 28, 2021
Antengene Corporation Limited announced the dosing of the first patient in China in a Phase I/II trial (the HATCH trial) of eltanexor (ATG-016), a next-generation selective inhibitor of…
Read More...

Tagrisso approved in the EU for the adjuvant treatment of patients with early-stage EGFR-mutated…

May 28, 2021
AstraZeneca’s Tagrisso (osimertinib) has been approved in the European Union (EU) for the adjuvant treatment of adult patients with early-stage (IB, II and IIIA) epidermal growth factor…
Read More...

Novartis and Molecular Partners announce start of EMPATHY clinical trial for ensovibep for the…

May 28, 2021
Novartis and Molecular Partners announced the start of the clinical trial EMPATHY, a Phase 2 and 3 study, to explore the use of its novel DARPin therapeutic candidate ensovibep (MP0420)…
Read More...

Menarini Silicon Biosystems launches new breakthrough DEPArray PLUS image-based cell sorter to…

May 27, 2021
Menarini Silicon Biosystems, a pioneer of liquid biopsy and single cell technologies, announced the launch of the new highly automated DEPArray PLUS, now available with 9 fluorescent…
Read More...

Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic…

May 27, 2021
Seelos Therapeutics, Inc. announced it has received European Orphan Drug Designation for SLS-005 in amyotrophic lateral sclerosis (ALS) from the European Medicines Agency (EMA)…
Read More...

Prestige Announces Agreement to Expand Eye Care Offering with Acquisition of TheraTears

May 27, 2021
Prestige Consumer Healthcare Inc. announced that it has entered into a definitive agreement to acquire a portfolio of over-the-counter consumer brands from specialty pharmaceutical…
Read More...
Prev Next
RNA-Targeted Drug Discovery & Development Summit
mRNA Process Development & CMC Summit 2026
TPD & Induced Proximity Summit
Measuring Patient Engagement Summit Europe
Oligonucleotides Analytical Development & CMC Summit
11th CAR-TCR Summit
COPD Drug Development Summit
2nd Operationalize: Expanded Access Programs Summit West
Neuropsychiatric Drug Development Summit
International Neoantigen Summit
Lab Ops & Facility Management for Biopharma West Summit
10th IPF Summit
Medical Device Software Development Summit
Liquid Biopsy for Precision Oncology Summit East Coast
ADC Linker & Conjugation Summit
TRP Supply Chain & Manufacturing Summit
Covalent Drug Discovery & Development Summit
7th Genome Editing Therapeutics Summit
16th World Clinical Biomarkers & Companion Diagnostics Summit
Lipid Nanoparticles Development Summit Europe
iPSC Drug Development Summit
17th World ADC San Diego
Oligonucleotides for CNS Summit
In Vivo Cell Engineering & Gene Editing Summit
Obesity & Weight Loss Drug Development Summit
T-Cell Engager Therapeutics Summit
mRNA-Based Therapeutics Summit
About Us

Pharma Journalist

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry.

Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry.

Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.

Recent Posts
  • Arcturus Partners With Thermo Fisher on Cystic Fibrosis mRNA Therapy
  • Lonza Secures Nona’s BBB Technology for CNS Drug Development
  • Ipsen Acquires Memo Therapeutics to Advance BK Virus Treatment
  • AlzeCure Licenses Alzheimer’s Drug Candidate ACD856 in $2.2B Deal
  • Inocras, AimedBio Partner to Advance ADC Precision Oncology Development

Industry Reports

Amgen Acquires Dark Blue to Advance Novel AML Treatments

Takeda Expands Entyvio Options Through Halozyme Technology…

Inductive Bio Wins $21M to Build AI Drug Toxicity Models

Alkermes Boosts Offer to Acquire Avadel in Deal Worth Up to…

Novartis Completes Acquisition of Tourmaline Bio to…

Press Releases

Advancing Respiratory Medicine Following ATS – What Now?

World ADC San Diego Unveils Preliminary Agenda for 17th…

Regeneron Goes All In on Radiopharma with $2.1B Telix Deal…

IQ MPS Leaders to Share Industry Progress on Advancing In…

4th ADC Linker & Conjugation Summit Announces 2026…

  • About
  • Advertise
  • Subscribe
  • Contact
© 2026 - Pharma Journalist. All Rights Reserved.
Pharma Journalist is a product of
Sign in

Welcome, Login to your account.

Forget password?
Sign in

Recover your password.

A password will be e-mailed to you.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.